Introduction
============

The human papillomavirus (HPV) is one of the most common etiologic agent of sexually transmitted diseases, with high prevalence rates. Actually, more than 100 HPV types have been described, of which 40 can infect the mucosa of the anogenital tract in both, men and women. According to their oncogenic potential, those viruses are classified as high- or low-risk genotypes ([@B02]; De Villiers *et al.*, 2011). The high-risk oncogenic genotypes are those that are strongly associated with premalignant and malignant cervical lesions, mainly HPVs 16 and 18, being also responsible for 70% of invasive cervical cancer (CC) cases in Brazil ([@B17]).

In Brazil, cervical cancer is the second most common type of cancer in the female population, and the fourth major cause of death in women. For 2012, 17.540 new cases were expected, 17 cases per 100,000 women (MS, 2011). Highly accurate techniques and epidemiologic studies demonstrate the relationship between the development of cervical cancer and HPV. HPV-DNA has been detected in 99.7% of cervical cancer cases worldwide ([@B06]).

Although HPV infection is considered an integral part of cervical cancer development, an association between HPV infection, oncogenic genotypes persistence, and other risk factors, determine the development of cervical intraepithelial neoplasia (CIN), and cervical cancer ([@B27]). The risk factors include youth, a high number of sexual partners throughout life, early sexual activity, tobacco smoking, low socioeconomic status, and genetic factors ([@B14]; [@B09]; [@B12]), as well the 16 and/or 18 HPVs genotypes infection, responsible for 70% of invasive cervical cancer (CC) cases in Brazil ([@B17]). In addition, infections caused by human immunodeficiency virus (HIV), bacterial vaginosis (BV), *Trichomonas vaginalis* (TV), and by *Chlamydia trachomatis* (CT) were involved as co-factors for cervical cancer development, adjuvants of the neoplastic process ([@B10], [@B18]).

Based on these data, our study aimed to detect the prevalence of HPV infection, to identify HPV genotypes, and to analyze cervical cancer risk factors in a female population representative of Pelotas, Rio Grande do Sul, Brazil.

Materials and Methods
=====================

Study population
----------------

This is a cross-sectional study. From May 2010 to May 2011, 251 women seeking gynecologic care at the gynecological ambulatory clinic at the Pelotas Federal University School of Medicine (UFPel) fulfilling eligibility criteria (not pregnant, sexually active, and not menstruating), and agreeing to participate in the study, were sequentially selected. The study used a closed questionnaire adapted from a previous study ([@B23]), applied by a female trained interviewer. Routine gynecological exams (cervicitis indicators, visual inspection with acetic acid and Lugol's iodine), were realized, and included in the questionnaire, as well the patient's recorded information (last Pap test result).

The study was approved by the Ethics Committee of the Faculty of Medicine - Federal University of Pelotas in June 2009, and informed consent was obtained from all participants. All procedures were carried out in accordance with the guidelines of the Helsinki Declaration.

Sample collection and processing
--------------------------------

Two cervical samples were collected from each patient. The first, with an Ayre's spatula was placed on slides for Bacterial vaginosis (BV) and *Trichomonas vaginalis* (TV) analysis by the Gram method. The second sample was collected with a cytobrush, and placed into 1.5 mL eppendorf tubes containing 300 mL of Cell Lysis Solution (Puregene™ DNA Extraction Kit, *Gentra Systems* Minneapolis, MN). The tubes were submitted to digestion using 1.5 μL of Proteinase K (10 mg/mL, New England Biolabs, MA), and incubated overnight at room temperature. The genomic material (DNA) was extracted, according to manufacturer specifications. As control for extracted DNA quality, the human *TP53* gene PCR was performed, using the primers previously described ([@B11]). PCR were performed in a final reaction volume of 12 μL, and was carried out with one cycle 94 °C for 3 min, followed by 40 cycles at 94 °C for 30 s, 57 °C for 30, 72 °C for 30 s and a final extension for 3 min at 72 °C ([@B25]).

HPV detection was carried out using nested-PCR (nPCR) technique, which is performed in two rounds: the first using MY09/11 primers ([@B13]) and amplifying a 450 pb fragment, the second used GP5/6 internal primers ([@B24]), which amplify the 140 pb fragment. The MY90/11 PCR reaction was performed in a final volume of 25 μL, and the conditions were as follows: 40 cycles of denaturation (1 min at 95 °C), annealing (1 min at 55 °C), and extension (1 min at 72 °C) ([@B07]). In the second round, the conditions were 40 cycles of denaturation (30 s at 94 °C), annealing (30 s at 45 °C), and extension (30 s at 72 °C) ([@B08]). Both PCR reactions were preheated for 9 min at 95 °C, and a final extension for 5 min at 72 °C. All PCR products were visualized on a 2.0% agarose gel with GelRed™ (Biotium Inc., CA).

HPV sequencing
--------------

HPV positive PCR products were purified previously using the Gel Band purification kit (GE Healthcare, USA) according the manufacturer instructions. The sequencing was performed in a MegaBACE 1000 DNA sequencer (GE Healthcare, USA), using Dynamic ET-terminator technology. Chromatograms were assembled and analyzed using the ContigExpress^®^ module of the Vector NTI 10.0 suite (Invitrogen, USA). The assembled sequences were submitted to BLAST alignment ([www.nci.nlm.gov/BLAST](www.nci.nlm.gov/BLAST)), against sequences available in GenBank.

Statistical analyses
--------------------

Chi-square (χ^2^) test was used to evaluate the association between HPV presence (and their HR/LR genotypes) with the variables of questionnaire. A multivariate analysis was made using logistic regression applied to a hierarchical model. The analysis was performed using SPSS 16.0 software (SPSS, Chicago, IL). Differences were considered significant at p \< 0.05.

Results
=======

Four hundred women were approached to participate, but only 251 were considered eligible for the study. The mean age was 33.3 years old (median 34 years old), ranging from 18 to 45 years old. Most of the samples did not present endocervical mucupurulent discharge (77.2%), friability (70.8%), or cervical motion tenderness (84.6%). The visual inspection with acetic acid (VIA) and visual inspection with Lugol's iodine (VILI) were negative for sub-clinical lesions in 85.9% and 71.1% of the participants, respectively. The Gram test detected BV in 9.2% of the women, and TV in 2.8%. Of the Pap smear results, 54.2% were normal, 38.6% inflammatory, 0.8% with ASCUS, 0.4% showed presence HPV, 2.1% indicated NIC I, and 0.4% indicated NIC II. Colposcopies were abnormal in 5% of the participants (data not show). The behavioral and sociodemographic characteristics are showed on [Table 1](#t01){ref-type="table"}. HPV was detected in 29.9% (N = 75), HR-HPV in 25.3%, and LR-HPV in 2.9% of the samples ([Table 2](#t02){ref-type="table"}). The most frequent genotype was HPV-16 (41.3%), followed by HPV-18 (17.3%), and HPV-33 (9.3%). The genotypes HPV-6 (2.7%), −31 (2.7%), −43 (1.3%), −45 (1.3%), −54 (4.0%), −56 (4.0%), −58 (4.0%), −70 (1.3) and −81 (2.7%) were also found. Six samples (8.0%) could not classified by sequencing due to overlap of the sequence-peaks. These were categorized as HPV-X ([Figure 1](#f01){ref-type="fig"}).

###### 

Distribution of socioeconomic, demographic and behavioral characteristics.

  Variable                         (%)
  -------------------------------- ------
  Age (years)                      
  18 -- 24                         17.5
  25 -- 30                         21.9
  31 -- 35                         17.9
  36 -- 39                         19.9
  40 -- 45                         22.7
  Skin color                       
  White                            65.7
  Black                            12.4
  Others                           21.9
  Reading ability                  
  Yes                              98.0
  No                               2.0
  Schooling (years)                
  0                                2.0
  1--4                             12.9
  5--8                             37.5
  9--11                            14.9
  ≥ 12                             32.7
  Marital status                   
  Married/consensual union         81.3
  Single                           11.2
  Separated/divorced/widowed       7.6
  Live alone                       
  Yes                              2.8
  No                               97.2
  Family Income (minimum wages)    
  0 -- 1                           25.5
  2                                41.3
  3                                23.5
  ≥ 4                              9.7
  Cigarette smoking                
  Current smoker                   19.9
  Ex-smoker                        24.7
  Never smoker                     55.4
  Alcohol consume (last 4 weeks)   
  At least once a week             17.1
  Less than once a week            29.5
  Never                            53.4
  Pregnancy                        
  Yes                              81.7
  No                               18.3
  Use of condom (in life)          
  Yes                              90.0
  No                               10.0
  Sexual activity began (years)    
  ≤ 12                             2.8
  13 -- 15                         33.1
  16 -- 18                         49.8
  ≥ 19                             14.3
  Sexual partners (in life)        
  1                                30.8
  2 -- 4                           44.4
  5 -- 8                           15.2
  ≥ 9                              9.6
  STD detection (last 12 months)   
  Yes                              6.8
  No                               93.2
  Last Pap test                    
  Never                            4.4
  \< 3 years                       74.9
  \> 3 years                       15.1
  Don't remember                   5.6

###### 

HPV detection and oncogenic potential.

  Variables                 Number                                (%)
  ------------------------- ------------------------------------- ------
  HPV                       251                                   
  Positive                                                        29.9
  Negative                                                        70.1
  HPV oncogenic potential   69[\*](#tfn01){ref-type="table-fn"}   
  High risk                                                       89.9
  Low risk                                                        10.1

HPV positives by nPCR.

![HPV genotypes identified by sequencing.](bjm-45-689-g001){#f01}

The bivariate analyses didn't show statistic significance in relation to behavioral characteristics, although it was observed that HPV infection occurred mostly in women who were ex-smokers (35.5%), had consumed alcohol at least once a week (34.9%), had never been pregnant (45.7%), began sexual activities between 13--15 years of age (35.4%), had from 2 to 4 sexual partners in life (26.9%), had STD detected in the last 12 months (35.3%), and whose last Pap test was in less than 3 years (32.3%). Cervicitis indicators showed that 30.1% of the samples did not present endocervical mucupurulent discharge, or friability at (31.6%); cervical motion tenderness was observed in 31.6% of the women ([Table 3](#t03){ref-type="table"}). The VIA inspection was positive in 34.3% of the participants, and VILI inspection in 29.6%. The presence of BV and TV was observed for 31.8% and 28.6% of the patients respectively. The cytological results for HPV presence, and NIC II was confirmed by nPCR for all (p = 0.362). The colposcopy results were abnormal in 41.7% of the HPV positive cases (p = 0.379). In relation to high or low risk HPV infection, and variables, it was observed that all high risk HPV infections showed a direct association (100%) with NIC I and NIC II Pap test results (p = 0.470). No statistical difference was also found in the multivariate analyses (data not show).

###### 

Frequency distribution of HPV infection according Cervicitis indicators, visual inspection, bacterial infection and Pap test results.

  Variables                                      HPV infection   
  ---------------------------------------------- --------------- -------
  Endocervical mucupurulent discharge                            
  Yes                                            28.1            71.9
  No                                             30.1            69.9
                                                 p = 0.773       
  Friablility                                                    
  Yes                                            26.0            74.0
  No                                             31.6            98.4
                                                 p = 0.379       
  Cervical motion tenderness                                     
  Yes                                            31.6            68.4
  No                                             29.7            70.3
                                                 p = 0.813       
  Visual inspection with acetic acid (VIA)                       
  Positive                                       34.3            65.7
  Negative                                       28.6            71.4
                                                 p = 0.497       
  Visual inspection with Lugol's iodine (VILI)                   
  Positive                                       29.6            70.4
  Negative                                       29.1            70.9
                                                 p = 0.946       
  Vaginosis                                                      
  Positive                                       31.8            68.2
  Negative                                       29.0            71.0
                                                 p = 0.783       
  *Trichomonas vaginalis*                                        
  Positive                                       28.6            71.4
  Negative                                       29.3            70.7
                                                 p = 0.967       
  Pap test results                                               
  Normal                                         28.1            71.9
  Inflammatory                                   34.1            65.9
  ASCUS                                          0               100.0
  HPV                                            100.0           0
  NIC I                                          40.0            60.0
  NIC II                                         100.0           0
  Inconclusive                                   25.5            75.0
                                                 p = 0.362       
  Colposcopy                                                     
  Normal                                         29.7            70.3
  Abnormal                                       41.7            58.3
                                                 p = 0.379       

Discussion
==========

Brazil has a population of 69.14 million women who are at risk for cervical cancer development, and current estimates indicate that 14.1% of the women in the general population have harbored a cervical HPV infection at some time in their lives. A total 70.7% of invasive cervical cancers are attributed to HPV-16 or -18 ([@B28]). HPV infection prevalence in Brazil varies between 7% and 43%, according to a systematic review of the literature performed in four Brazilian regions ([@B01]). In this study, the prevalence was within the expected range (29.9%). Two other studies were realized in the same state in Southern Brazil: on the first was found a higher HPV infection prevalence (60%) in HIV negative women, (with or without cervical lesions) than reported here ([@B05]). In the second study [@B21] found that HPV infection was lower (12.3%). In the Northern regions, [@B19] conducted a screening study in 1021 women in the city of Belém, and observed an HPV prevalence of 12.4%.

In this study, the most prevalent genotype was HPV-16, followed by HPV-18. These findings are consistent with [@B20], which in a study performed in Rio de Janeiro (with PCR for DNA-HPV detection in 297 HPV positive women), noted a prevalence of 28% for HPV-16, and 14.4% for HPV-18, differing by only a third from the most prevalent genotype, which was reported for HPV-45 (7.6%), and in our study was observed for HPV-33 (9.3%). However, [@B15] carried out a study with 248 women in the city of Recife, and also observed that the HPV-33 genotype was the third most prevalent (13.9%), a similar percentage to the present study. The high prevalence of oncogenic genotypes found in this study indicates the need for frequent monitoring, and suggests nPCR technique for DNA-HPV detection as an alternative to early identification of women at high risk for cervical cancer development. Previous studies have already demonstrated that the use of primers pair MY09/11 and GP5/GP6 in a nPCR assay increases the sensitivity of HPV detection compared with PCR assay ([@B22]; [@B03]).

Recent data ([@B26]) show that there has occurred a large decrease in the number of smokers in Brazilian population, going from 16.2% in year of 2006 to less than 15% in 2011. These data show that the state capital of Rio Grande do Sul, Porto Alegre, has the largest number of smokers (23%), higher than the one found in this study. The survey research also identifies that there was an increase in Pap tests realized in the last three years (89.6%) in women who had more than 12 years schooling. This study also observed a higher percentage of Pap tests realized during the same period (\< 3 years), but didn't found a relation with higher schooling. Some studies correlate potential risk factors with HPV infection. In this study, it wasn't possible to observe this relationship. One of the explanations could be the increasing awareness of condom use and smoking health harms that may be contributed to these findings.

Since the study is clinical based, the results should be considered as preliminary, giving an indication of the high prevalence of HPV infection by oncogenic genotypes found in women from Pelotas, but not being capable of correlating the infection with behavioral and socio-demographic factors. Further population based studies from the same geographical area are needed. The current research helps to identify regional differences of HPV genotypes, given the large area and population differences exist in Brazil, and is a contribution to the medical care of the population of Pelotas and to research centers studying human papillomavirus.
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